1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Automation in Biopharma Revenue
1.4 Market Analysis by Type
1.4.1 Global Automation in Biopharma Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 IoT
1.4.3 AI
1.4.4 Digital Twin
1.4.5 AR & VR
1.4.6 Predictive Analytics
1.4.7 Cloud Computing
1.5 Market by Application
1.5.1 Global Automation in Biopharma Market Share by Application: 2021-2026
1.5.2 Large Pharmaceutical Factory
1.5.3 Small and Medium-sized Pharmaceutical Factory
1.5.4 Biopharmaceutical Laboratory
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Automation in Biopharma Market
1.8.1 Global Automation in Biopharma Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Automation in Biopharma Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Automation in Biopharma Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Automation in Biopharma Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Automation in Biopharma Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Automation in Biopharma Sales Volume Market Share by Region (2015-2020)
3.2 Global Automation in Biopharma Sales Revenue Market Share by Region (2015-2020)
3.3 North America Automation in Biopharma Sales Volume
3.3.1 North America Automation in Biopharma Sales Volume Growth Rate (2015-2020)
3.3.2 North America Automation in Biopharma Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Automation in Biopharma Sales Volume
3.4.1 East Asia Automation in Biopharma Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Automation in Biopharma Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Automation in Biopharma Sales Volume (2015-2020)
3.5.1 Europe Automation in Biopharma Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Automation in Biopharma Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Automation in Biopharma Sales Volume (2015-2020)
3.6.1 South Asia Automation in Biopharma Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Automation in Biopharma Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Automation in Biopharma Sales Volume (2015-2020)
3.7.1 Southeast Asia Automation in Biopharma Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Automation in Biopharma Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Automation in Biopharma Sales Volume (2015-2020)
3.8.1 Middle East Automation in Biopharma Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Automation in Biopharma Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Automation in Biopharma Sales Volume (2015-2020)
3.9.1 Africa Automation in Biopharma Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Automation in Biopharma Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Automation in Biopharma Sales Volume (2015-2020)
3.10.1 Oceania Automation in Biopharma Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Automation in Biopharma Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Automation in Biopharma Sales Volume (2015-2020)
3.11.1 South America Automation in Biopharma Sales Volume Growth Rate (2015-2020)
3.11.2 South America Automation in Biopharma Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Automation in Biopharma Sales Volume (2015-2020)
3.12.1 Rest of the World Automation in Biopharma Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Automation in Biopharma Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Automation in Biopharma Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Automation in Biopharma Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Automation in Biopharma Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Automation in Biopharma Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Automation in Biopharma Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Automation in Biopharma Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Automation in Biopharma Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Automation in Biopharma Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Automation in Biopharma Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Automation in Biopharma Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Automation in Biopharma Sales Volume Market Share by Type (2015-2020)
14.2 Global Automation in Biopharma Sales Revenue Market Share by Type (2015-2020)
14.3 Global Automation in Biopharma Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Automation in Biopharma Consumption Volume by Application (2015-2020)
15.2 Global Automation in Biopharma Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Automation in Biopharma Business
16.1 GE
16.1.1 GE Company Profile
16.1.2 GE Automation in Biopharma Product Specification
16.1.3 GE Automation in Biopharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Siemens
16.2.1 Siemens Company Profile
16.2.2 Siemens Automation in Biopharma Product Specification
16.2.3 Siemens Automation in Biopharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Thermo Fisher Scientific
16.3.1 Thermo Fisher Scientific Company Profile
16.3.2 Thermo Fisher Scientific Automation in Biopharma Product Specification
16.3.3 Thermo Fisher Scientific Automation in Biopharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 PerkinElmer
16.4.1 PerkinElmer Company Profile
16.4.2 PerkinElmer Automation in Biopharma Product Specification
16.4.3 PerkinElmer Automation in Biopharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Sartorius
16.5.1 Sartorius Company Profile
16.5.2 Sartorius Automation in Biopharma Product Specification
16.5.3 Sartorius Automation in Biopharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Tecan Journal
16.6.1 Tecan Journal Company Profile
16.6.2 Tecan Journal Automation in Biopharma Product Specification
16.6.3 Tecan Journal Automation in Biopharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Zenith (Cognizant)
16.7.1 Zenith (Cognizant) Company Profile
16.7.2 Zenith (Cognizant) Automation in Biopharma Product Specification
16.7.3 Zenith (Cognizant) Automation in Biopharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Peak Analysis & Automation
16.8.1 Peak Analysis & Automation Company Profile
16.8.2 Peak Analysis & Automation Automation in Biopharma Product Specification
16.8.3 Peak Analysis & Automation Automation in Biopharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Bruker Corporation
16.9.1 Bruker Corporation Company Profile
16.9.2 Bruker Corporation Automation in Biopharma Product Specification
16.9.3 Bruker Corporation Automation in Biopharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Rockwell
16.10.1 Rockwell Company Profile
16.10.2 Rockwell Automation in Biopharma Product Specification
16.10.3 Rockwell Automation in Biopharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 BioProcess International
16.11.1 BioProcess International Company Profile
16.11.2 BioProcess International Automation in Biopharma Product Specification
16.11.3 BioProcess International Automation in Biopharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 RheoSense, Inc.
16.12.1 RheoSense, Inc. Company Profile
16.12.2 RheoSense, Inc. Automation in Biopharma Product Specification
16.12.3 RheoSense, Inc. Automation in Biopharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Novasep
16.13.1 Novasep Company Profile
16.13.2 Novasep Automation in Biopharma Product Specification
16.13.3 Novasep Automation in Biopharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 TetraScience
16.14.1 TetraScience Company Profile
16.14.2 TetraScience Automation in Biopharma Product Specification
16.14.3 TetraScience Automation in Biopharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.15 Werum
16.15.1 Werum Company Profile
16.15.2 Werum Automation in Biopharma Product Specification
16.15.3 Werum Automation in Biopharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.16 Emerson
16.16.1 Emerson Company Profile
16.16.2 Emerson Automation in Biopharma Product Specification
16.16.3 Emerson Automation in Biopharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Automation in Biopharma Manufacturing Cost Analysis
17.1 Automation in Biopharma Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Automation in Biopharma
17.4 Automation in Biopharma Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Automation in Biopharma Distributors List
18.3 Automation in Biopharma Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Automation in Biopharma (2021-2026)
20.2 Global Forecasted Revenue of Automation in Biopharma (2021-2026)
20.3 Global Forecasted Price of Automation in Biopharma (2015-2026)
20.4 Global Forecasted Production of Automation in Biopharma by Region (2021-2026)
20.4.1 North America Automation in Biopharma Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Automation in Biopharma Production, Revenue Forecast (2021-2026)
20.4.3 Europe Automation in Biopharma Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Automation in Biopharma Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Automation in Biopharma Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Automation in Biopharma Production, Revenue Forecast (2021-2026)
20.4.7 Africa Automation in Biopharma Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Automation in Biopharma Production, Revenue Forecast (2021-2026)
20.4.9 South America Automation in Biopharma Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Automation in Biopharma Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Automation in Biopharma by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Automation in Biopharma by Country
21.2 East Asia Market Forecasted Consumption of Automation in Biopharma by Country
21.3 Europe Market Forecasted Consumption of Automation in Biopharma by Countriy
21.4 South Asia Forecasted Consumption of Automation in Biopharma by Country
21.5 Southeast Asia Forecasted Consumption of Automation in Biopharma by Country
21.6 Middle East Forecasted Consumption of Automation in Biopharma by Country
21.7 Africa Forecasted Consumption of Automation in Biopharma by Country
21.8 Oceania Forecasted Consumption of Automation in Biopharma by Country
21.9 South America Forecasted Consumption of Automation in Biopharma by Country
21.10 Rest of the world Forecasted Consumption of Automation in Biopharma by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer